Literature DB >> 29234187

Efficacy of ε-Poly-L-lysine as an Antibacterial Additive for Platelets Stored at Room Temperature.

Hosein Timori Naghadeh1, Zohreh Sharifi2, Saeideh Soleimani2, Zainab Pir Mohamad Jamaat3, Shirin Ferdowsi4,5.   

Abstract

Entities:  

Year:  2017        PMID: 29234187      PMCID: PMC5722972     

Source DB:  PubMed          Journal:  Iran J Med Sci        ISSN: 0253-0716


× No keyword cloud information.
Dear Editor, The need for platelet concentrates (PCs) is currently growing while the use of packed red blood cells is on the decline. PCs that are stored at room temperature (20-24 °C) provide a bacterial growth condition and are regarded as the main cause of bacterially induced transfusion disorders.[1] Recently, the antibacterial effects of several agents have been evaluated in platelets.[1,2] Epsilon-Poly-L-lysine (ε-PLL) is a polypeptide composed of 27 to 33 identical L-lysine subunits, which was studied for the first time in Japan as an antimicrobial agent in PCs.[3] In the present study, PCs units were collected from healthy blood donors who visited the Blood Bank of Tehran (Iran) to determine the efficacy of the bactericidal activity of ε-PLL. Informed consent was obtained from all donors and the project was approved by the Research Ethics Committees of the Iranian blood transfusion organization. The results indicated that the growth of S. epidermis, Pseudomonas aerugenosa, E. coli, and S. aureus in PCs was completely inhibited after 8 days of incubation with 100 µg/mL ε-PLL. There were no significant differences between the untreated controls and the PCs treated with ε-PLL in terms of the PCs quality variables (table 1). These findings are consistent with a previous report in Japan. In a study by Tanaka et al.,[3] ε-PLL was found to inhibit the growth of the bacterial contaminants S. aureus, B. cereus, and K. oxytoca in the concentrations of 200 and 50 µg/mL in the plasma and PAS-IIIM PCs, respectively, after 8 days of incubation. Moreover, they demonstrated that ε-PLL did not significantly affect the quality of the PCs except for increased CD62P expression. The results of a study by Liu et al.[4] also showed the combination of ε-polylysine and nisin has synergistic antimicrobial activity against E. coli, B. subtilis, and S. aureus. Samadi et al.[5] investigated the antimicrobial activities of magnesium oxide nanoparticles and ε-PLL against two major foodborne bacteria, Escherichia coli O157:H7 and Listeria monocytogenes. They demonstrated the inhibitory effects of both substances. In a study by Zhao et al.,[6] the amphiphilic e-poly-L-lysine (EPL)/poly (e-caprolactone) (PCL) copolymer showed a broad-spectrum antibacterial activity against Escherichia coli, Staphylococcus aureus, and Bacillus subtilis.
Table 1

Na, K, mean PLT volume (MPV), PLT count, and PH changes in PCs inoculated with S. epidermis, Staphylococcus aureus, Pseudomonas aerugenosa, and Escherchia coli after the 8-day storage (PCs units with ε-PLL is compared with control PCs without ε-PLL)

VariableControl PCs without ε-PLLPCs with 50 µg/mL ε-PLLP valuePCs with 100 µg/mL ε-PLLP valuePCs with 200 µg/mL ε-PLLP value
S. epidermis
 Na174±1171±30.560172±10.698171±20.127
 K3.1±0.103.2±0.090.5553.5±0.120.1173.3±0.100.542
 MPV10.4±0.510.1±0.60.86010.2±0.40. 31010.2±0.70.604
 PLT count/µL1,100,100±278,0001,052,500±295,0000.5481,000,100±277,1000.221990,550±292,000*0.000
 PH7.2±0.107.15±0.90.3007.0±0.110.5306.99±0.150.137
Staphylococcus aureus
 Na170±2170±10.937171±20.824173±10.571
 K3.0±0.123.1±0.170.5983.3±0.130.5553.3±0.090.435
 MPV9.2±0.89.3±0.60.36910.0±0.80.2319.7±0.080.381
 PLT count/µL1,116,000±284,0001,112,000±304,0000.1371,120,000±311,0000.1191,013,000±321,0000.150
 PH6.95±0.107.9±0.90.0607.12±0.140.2047.07±0.100.017
Pseudomonas aerugenosa
 Na169±3171±20.520172±20.561172±10.582
 K3.3±0.123.6±0.170.3903.4±0.130.5503.6±0.120.650
 MPV10.2±0.810.3±0.60.44012.5±9*0.0008.5±0.7*0.000
 PLT count/µL587,000±271,000559,000±270,0000.29564,000±285,0000.360528,000±293,000*0.001
 PH7.1±0.97.0±0.110.4526.95±0.140.4617.12±0.90.344
Escherchia coli
 Na170±2171±10.561172±10.560172±30.698
 K3.2±0.113.2±0.140.5503.3±0.110.5453.8±0.090.571
 MPV10.0±0.710.1±0.90.30010.2±0.90.36010.4±0.80. 310
 PLT count/µL1,156,000±280,0001,153,000±280,0000.3611,132,000±321,0000.5381,128,000±313,0000.212
 PH7.2±0.117.12±0.140.4607.15±0.110.3107.0±0.130.503

P<0.05 were considered statistically significant. Analysis of paired t test was used to compare values

Na, K, mean PLT volume (MPV), PLT count, and PH changes in PCs inoculated with S. epidermis, Staphylococcus aureus, Pseudomonas aerugenosa, and Escherchia coli after the 8-day storage (PCs units with ε-PLL is compared with control PCs without ε-PLL) P<0.05 were considered statistically significant. Analysis of paired t test was used to compare values The main limitation of the present study was that the samples of each PCs were obtained on days 1, 3, 5, and 8 to determine the colony count of PCs inoculated with each bacterium. Thus, the trend of quality parameter changes was not studied. Consequently, more research on this topic is required prior to its application in clinical trials. In conclusion, the presented data further support the proposal that ε-PLL inhibits the growth of the bacterial contaminants in room temperature stored platelets. Conflict of Interest: None declared.
  3 in total

1.  Preclinical safety evaluation of human platelets treated with antimicrobial peptides in severe combined immunodeficient mice.

Authors:  Marta Bosch-Marcé; Ketha V K Mohan; Monique P Gelderman; Patricia L Ryan; Estelle Russek-Cohen; Chintamani D Atreya
Journal:  Transfusion       Date:  2013-06-30       Impact factor: 3.157

2.  Recombinant human lipocalin 2 acts as an antibacterial agent to prevent platelet contamination.

Authors:  Zahra Bakhshandeh; Raheleh Halabian; Abbas Ali Imani Fooladi; Ali Jahanian-Najafabadi; Mohammad Ali Jalili; Mehryar Habibi Roudkenar
Journal:  Hematology       Date:  2014-03-01       Impact factor: 2.269

3.  Application of the bactericidal activity of epsilon-poly-l-lysine to the storage of human platelet concentrates.

Authors:  Shigenori Tanaka; Tomoya Hayashi; Hidemi Tateyama; Kazuaki Matsumura; Suong-Hyu Hyon; Fumiya Hirayama
Journal:  Transfusion       Date:  2009-11-20       Impact factor: 3.157

  3 in total
  1 in total

Review 1.  Breaking down the cell wall: Still an attractive antibacterial strategy.

Authors:  Jingxuan Zhou; Yi Cai; Ying Liu; Haoyue An; Kaihong Deng; Muhammad Awais Ashraf; Lili Zou; Jun Wang
Journal:  Front Microbiol       Date:  2022-09-23       Impact factor: 6.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.